|
Video: Compound Annual Growth Rate (CAGR) Definition
|
|
Date |
Open |
High |
Low |
Close |
Volume |
04/18/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
0 | 04/19/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
0 | 04/22/2024 |
$0.07 |
$0.07 |
$0.07 |
$0.07 |
0 | 04/23/2024 |
$0.08 |
$0.08 |
$0.08 |
$0.08 |
100 | 04/24/2024 |
$0.08 |
$0.08 |
$0.08 |
$0.08 |
0 |
|
Enzon Pharmaceuticals receives royalty revenues from existing licensing arrangements with other companies primarily related to sales of four marketed drug products, namely, PegIntron®, Sylatron®, Macugen® and CIMZIA®. PegIntron® is used for the treatment of chronic hepatitis C. Sylatron® is used for the treatment of melanoma. Macugen® is used for the treatment of neovascular (wet) age-related macular degeneration. CIMZIA® is used for the treatment of Crohn's disease and rheumatoid arthritis. Co. has no clinical operations and limited corporate operations. | |
|
ENZN (ENZN) has the following price history information. Looking back at ENZN historical stock prices for the last five trading days, on April 18, 2024, ENZN opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 0 shares. On April 19, 2024, ENZN opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 0 shares. On April 22, 2024, ENZN opened at $0.07, traded as high as $0.07 and as low as $0.07, and closed at $0.07. Trading volume was a total of 0 shares. On April 23, 2024, ENZN opened at $0.08, traded as high as $0.08 and as low as $0.08, and closed at $0.08. Trading volume was a total of 100 shares. On April 24, 2024, ENZN opened at $0.08, traded as high as $0.08 and as low as $0.08, and closed at $0.08. Trading volume was a total of 0 shares.
ENZN Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into ENZN shares, starting with a $10,000 purchase of ENZN, and working forward through the historical stock price information to today.
Growth of $10,000.00
With Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$0.88 |
|
End price/share: |
$0.08 |
|
Starting shares: |
11,363.64 |
|
Ending shares: |
103,315.74 |
|
Dividends reinvested/share: |
$1.33 |
|
Total return: |
-17.35% |
|
Average Annual Total Return: |
-1.89% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$8,263.34 |
|
Years: |
10.00 |
|
|
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
04/28/2014 |
|
End date: |
04/24/2024 |
|
Start price/share: |
$0.88 |
|
End price/share: |
$0.08 |
|
Dividends collected/share: |
$1.33 |
|
Total return: |
60.23% |
|
Average Annual Total Return: |
4.83% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$16,025.06 |
|
Years: |
10.00 |
|
|
|
Date |
Close |
04/18/2024 | $0.07 | 04/19/2024 | $0.07 | 04/22/2024 | $0.07 | 04/23/2024 | $0.08 | 04/24/2024 | $0.08 |
|
|